Innovator companies should focus on innovations

Author(s): Professor Theodor Dingermann, PhD

Abstract: Despite biopharmaceuticals having an enormous potential value for our health, they have also become a serious threat to our healthcare systems. Submitted: 22 June 2011; Revised manuscript received: 6 October 2011; Accepted: 11 October 2011 Recombinant drugs, or biologicals as they are widely termed, are highly complex drug substances that have added tremendous treatment […]

Read more →